310 related articles for article (PubMed ID: 23122780)
21. A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.
Fumagalli D; Bedard PL; Nahleh Z; Michiels S; Sotiriou C; Loi S; Sparano JA; Ellis M; Hylton N; Zujewski JA; Hudis C; Esserman L; Piccart M;
Lancet Oncol; 2012 Jun; 13(6):e240-8. PubMed ID: 22652232
[TBL] [Abstract][Full Text] [Related]
22. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
Calkins H; Kuck KH; Cappato R; Brugada J; Camm AJ; Chen SA; Crijns HJ; Damiano RJ; Davies DW; DiMarco J; Edgerton J; Ellenbogen K; Ezekowitz MD; Haines DE; Haissaguerre M; Hindricks G; Iesaka Y; Jackman W; Jalife J; Jais P; Kalman J; Keane D; Kim YH; Kirchhof P; Klein G; Kottkamp H; Kumagai K; Lindsay BD; Mansour M; Marchlinski FE; McCarthy PM; Mont JL; Morady F; Nademanee K; Nakagawa H; Natale A; Nattel S; Packer DL; Pappone C; Prystowsky E; Raviele A; Reddy V; Ruskin JN; Shemin RJ; Tsao HM; Wilber D
Europace; 2012 Apr; 14(4):528-606. PubMed ID: 22389422
[No Abstract] [Full Text] [Related]
23. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
Kappetein AP; Head SJ; Généreux P; Piazza N; van Mieghem NM; Blackstone EH; Brott TG; Cohen DJ; Cutlip DE; van Es GA; Hahn RT; Kirtane AJ; Krucoff MW; Kodali S; Mack MJ; Mehran R; Rodés-Cabau J; Vranckx P; Webb JG; Windecker S; Serruys PW; Leon MB;
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):6-23. PubMed ID: 23084102
[TBL] [Abstract][Full Text] [Related]
24. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
Glynne-Jones R; Mawdsley S; Novell JR
Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
[TBL] [Abstract][Full Text] [Related]
25. Endpoints for clinical trials and revised assessment in neuro-oncology.
Butowski N; Chang SM
Curr Opin Neurol; 2012 Dec; 25(6):780-5. PubMed ID: 23007010
[TBL] [Abstract][Full Text] [Related]
26. [Time-to-event endpoints--definitions and methodological issues].
Sato A; Ishizuka N; Fukuda H
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1057-64. PubMed ID: 12938258
[TBL] [Abstract][Full Text] [Related]
27. Controversies in design and interpretation of adjuvant clinical trials.
Cuzick J
Cancer Invest; 2010; 28 Suppl 1():28-34. PubMed ID: 20653405
[TBL] [Abstract][Full Text] [Related]
28. Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review.
Zichi C; Paratore C; Gargiulo P; Mariniello A; Reale ML; Audisio M; Bungaro M; Caglio A; Gamba T; Perrone F; Di Maio M
Eur J Cancer; 2021 May; 149():49-60. PubMed ID: 33823362
[TBL] [Abstract][Full Text] [Related]
29. Joint modeling of progression-free survival and death in advanced cancer clinical trials.
Dejardin D; Lesaffre E; Verbeke G
Stat Med; 2010 Jul; 29(16):1724-34. PubMed ID: 20572123
[TBL] [Abstract][Full Text] [Related]
30. Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group.
Stone AM; Bushnell W; Denne J; Sargent DJ; Amit O; Chen C; Bailey-Iacona R; Helterbrand J; Williams G;
Eur J Cancer; 2011 Aug; 47(12):1763-71. PubMed ID: 21435858
[TBL] [Abstract][Full Text] [Related]
31. An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints.
Jenkins M; Stone A; Jennison C
Pharm Stat; 2011; 10(4):347-56. PubMed ID: 22328327
[TBL] [Abstract][Full Text] [Related]
32. A new and rapid scoring system to assess the scientific evidence from clinical trials.
Silber S
J Interv Cardiol; 2006 Dec; 19(6):485-92. PubMed ID: 17107362
[TBL] [Abstract][Full Text] [Related]
33. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
Samalin L; Llorca PM
Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
[TBL] [Abstract][Full Text] [Related]
34. Does the decision in a validation process of a surrogate endpoint change with level of significance of treatment effect? A proposal on validation of surrogate endpoints.
Sertdemir Y; Burgut R
Contemp Clin Trials; 2009 Jan; 30(1):8-12. PubMed ID: 18809512
[TBL] [Abstract][Full Text] [Related]
35. Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.
Ponsioen CY; Chapman RW; Chazouillères O; Hirschfield GM; Karlsen TH; Lohse AW; Pinzani M; Schrumpf E; Trauner M; Gores GJ
Hepatology; 2016 Apr; 63(4):1357-67. PubMed ID: 26418478
[TBL] [Abstract][Full Text] [Related]
36. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
37. Interim futility analysis with intermediate endpoints.
Goldman B; LeBlanc M; Crowley J
Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
[TBL] [Abstract][Full Text] [Related]
38. The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases.
Lonn E
Pharmacoepidemiol Drug Saf; 2001; 10(6):497-508. PubMed ID: 11828831
[TBL] [Abstract][Full Text] [Related]
39. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
Kappetein AP; Head SJ; Généreux P; Piazza N; van Mieghem NM; Blackstone EH; Brott TG; Cohen DJ; Cutlip DE; van Es GA; Hahn RT; Kirtane AJ; Krucoff MW; Kodali S; Mack MJ; Mehran R; Rodés-Cabau J; Vranckx P; Webb JG; Windecker S; Serruys PW; Leon MB
Eur Heart J; 2012 Oct; 33(19):2403-18. PubMed ID: 23026477
[TBL] [Abstract][Full Text] [Related]
40. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
